Published in Vaccine on September 28, 2004
A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. J Virol (2007) 1.76
Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol (2007) 1.29
Construction of an infectious rhesus rhadinovirus bacterial artificial chromosome for the analysis of Kaposi's sarcoma-associated herpesvirus-related disease development. J Virol (2007) 1.16
Herpesvirus BACs: past, present, and future. J Biomed Biotechnol (2010) 1.08
A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system. J Virol Methods (2008) 1.06
The varicella-zoster virus genome. Curr Top Microbiol Immunol (2010) 1.02
Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts. J Virol (2007) 0.96
Viral bacterial artificial chromosomes: generation, mutagenesis, and removal of mini-F sequences. J Biomed Biotechnol (2012) 0.96
Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread. J Virol (2007) 0.94
Cloning human herpes virus 6A genome into bacterial artificial chromosomes and study of DNA replication intermediates. Proc Natl Acad Sci U S A (2009) 0.92
Epstein-Barr virus genetics: talking about the BAC generation. Herpesviridae (2010) 0.90
Cloning the simian varicella virus genome in E. coli as an infectious bacterial artificial chromosome. Arch Virol (2011) 0.90
Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice. Antiviral Res (2010) 0.86
Construction of a full-length infectious bacterial artificial chromosome clone of duck enteritis virus vaccine strain. Virol J (2013) 0.82
Varicella-zoster virus ORF49 functions in the efficient production of progeny virus through its interaction with essential tegument protein ORF44. J Virol (2013) 0.81
Experimental infection of Cynomolgus Macaques (Macaca fascicularis) with human varicella-zoster virus. J Virol (2012) 0.80
Characterization of the varicella-zoster virus ORF50 gene, which encodes glycoprotein M. J Virol (2010) 0.79
Varicella-zoster virus ORF 58 gene is dispensable for viral replication in cell culture. Virol J (2008) 0.79
Bacterial artificial chromosome derived simian varicella virus is pathogenic in vivo. Virol J (2013) 0.78
Human herpesvirus 6 major immediate early promoter has strong activity in T cells and is useful for heterologous gene expression. Virol J (2011) 0.76
Recombinant varicella-zoster virus vaccines as platforms for expression of foreign antigens. Adv Virol (2013) 0.76
Recent advances in cloning herpesviral genomes as infectious bacterial artificial chromosomes. Cell Cycle (2011) 0.75
Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science (2002) 4.13
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol (2004) 3.42
SOCS-1 participates in negative regulation of LPS responses. Immunity (2002) 3.39
Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg (2003) 3.12
Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol (2003) 3.02
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke (2014) 2.71
Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann Surg (2007) 2.51
Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol (2004) 2.43
Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol (2008) 2.35
Escape of mutant double-stranded DNA virus from innate immune control. Immunity (2004) 2.14
Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol (2003) 2.09
Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol (2002) 2.05
Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity (2003) 2.03
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol (2002) 1.92
Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J Virol (2007) 1.90
Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. J Gen Virol (2006) 1.83
Identification of proteins associated with murine cytomegalovirus virions. J Virol (2004) 1.72
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med (2005) 1.68
Evolutionarily conserved herpesviral protein interaction networks. PLoS Pathog (2009) 1.67
Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis (2009) 1.60
Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication. J Virol (2004) 1.59
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis (2002) 1.58
Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol (2004) 1.55
Is there still a role for total pancreatectomy? Ann Surg (2007) 1.52
The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis. J Virol (2004) 1.50
Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol (2011) 1.50
Assessment of functioning and disability after ischemic stroke. Stroke (2002) 1.48
UL74 of human cytomegalovirus contributes to virus release by promoting secondary envelopment of virions. J Virol (2008) 1.42
Human herpesvirus 6B infection of the large intestine of patients with diarrhea. Clin Infect Dis (2002) 1.40
Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses. Proc Natl Acad Sci U S A (2009) 1.37
Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J Virol (2004) 1.37
Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol (2004) 1.36
Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol (2003) 1.34
Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. J Virol (2004) 1.34
Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med (2003) 1.34
Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol (2013) 1.33
Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Towne long as BACs and site-directed mutagenesis using a PCR-based technique. Virology (2003) 1.32
Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J Virol (2002) 1.31
Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic (2008) 1.31
A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J Virol (2004) 1.28
Effect of antecolic reconstruction on delayed gastric emptying after the pylorus-preserving Whipple procedure. Arch Surg (2005) 1.24
Invertebrate herbivory along a gradient of plant species diversity in extensively managed grasslands. Oecologia (2006) 1.24
AP-1A and AP-3A lysosomal sorting functions. Traffic (2002) 1.22
Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope. J Virol (2004) 1.20
Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. J Immunol (2004) 1.20
High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood (2002) 1.17
Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg (2002) 1.16
The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. Blood (2007) 1.16
Mesh shrinkage and pain in laparoscopic ventral hernia repair: a randomized clinical trial comparing suture versus tack mesh fixation. Surg Endosc (2010) 1.16
Cytomegalovirus encodes a positive regulator of antigen presentation. J Virol (2006) 1.14
Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. Hum Gene Ther (2007) 1.13
Impact of invertebrate herbivory in grasslands depends on plant species diversity. Ecology (2010) 1.13
Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells (2009) 1.12
Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J Virol (2004) 1.11
The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope. J Virol (2003) 1.08
An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality. Europace (2010) 1.08
Management patterns and health care use after intracerebral hemorrhage. a cost-of-illness study from a societal perspective in Germany. Cerebrovasc Dis (2003) 1.08
Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. J Gen Virol (2002) 1.07
The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J Gen Virol (2002) 1.07
Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression. Virus Res (2002) 1.07
Human herpesvirus 6 encoded glycoprotein Q1 gene is essential for virus growth. Virology (2010) 1.07
Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency. J Virol (2004) 1.05
CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc Natl Acad Sci U S A (2013) 1.04
Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. J Immunol (2006) 1.04
Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J Clin Invest (2010) 1.04
Nitrogen supply affects arbuscular mycorrhizal colonization of Artemisia vulgaris in a phosphate-polluted field site. New Phytol (2005) 1.04
Stroke risk perception among participants of a stroke awareness campaign. BMC Public Health (2007) 1.03
Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus. J Virol (2006) 1.01
Human herpesvirus 6 glycoprotein complex formation is required for folding and trafficking of the gH/gL/gQ1/gQ2 complex and its cellular receptor binding. J Virol (2011) 1.00
Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J Virol (2010) 1.00
Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36. Parasitol Int (2010) 0.98
The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV. J Virol (2010) 0.97
Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts. PLoS One (2011) 0.97
Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts. J Virol (2007) 0.96
A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination. J Virol (2010) 0.96
Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus. J Virol (2003) 0.95
Health-enabling technologies for the elderly--an overview of services based on a literature review. Comput Methods Programs Biomed (2011) 0.95
Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity. Gastroenterology (2009) 0.95
Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus. Vaccine (2007) 0.95